Literature DB >> 33501980

Transferable Acinetobacter baumannii plasmid pDETAB2 encodes OXA-58 and NDM-1 and represents a new class of antibiotic resistance plasmids.

Haiyang Liu1,2,3, Robert A Moran4, Ying Chen1,2,3, Emma L Doughty4, Xiaoting Hua1,2,3, Yan Jiang1,2,3, Qingye Xu1,2,3, Linghong Zhang1,2,3, Jessica M A Blair4, Alan McNally4, Willem van Schaik4, Yunsong Yu1,2,3.   

Abstract

OBJECTIVES: To characterize a blaOXA-58- and blaNDM-1-containing MDR plasmid from a rare Acinetobacter baumannii lineage and compare it with related plasmids to explore the distribution and evolution of a new plasmid group.
METHODS: A. baumannii DETAB-P2 was isolated from a rectal swab of an intensive care patient. Antibiotic susceptibility was determined using broth microdilution. DETAB-P2 was mated with A. baumannii ATCC 17978 and putative transconjugants were characterized by S1/PFGE and Southern hybridization. WGS was performed on the Illumina and Oxford Nanopore platforms. MLST was performed with the Pasteur and Oxford schemes. Antibiotic resistance genes were identified with ABRicate. Plasmid sequence annotation was performed manually. Complete plasmids in GenBank with the same rep gene were used for comparative analyses.
RESULTS: A. baumannii DETAB-P2 was ST138 by the Pasteur scheme and a novel Oxford type, ST2209. It transferred blaOXA-58 and blaNDM-1 to ATCC 17978 in the 100 072 bp plasmid pDETAB2 that also carried bleMBL, sul2, aacC2d, tet(39), msr(E)-mph(E) and putative mercury resistance and RND efflux system determinants. pDETAB2 represents a new plasmid type, GR34, and contained 16 pdif sites and several novel dif modules. Only a 10 kbp core sequence is shared amongst pDETAB2 and 18 further GR34 plasmids in GenBank, with diverse accessory regions comprised of various dif modules.
CONCLUSIONS: GR34 plasmids are found in several Acinetobacter species from diverse environments. They display considerable variation in accessory content owing to the presence of pdif sites and an array of dif modules, some of which contain antibiotic resistance genes.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 33501980     DOI: 10.1093/jac/dkab005

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Coexistence of blaOXA-58 and blaNDM-1 on a Novel Plasmid of GR59 from an Acinetobacter towneri Isolate.

Authors:  Ying Li; Yichuan Qiu; Chengju Fang; Xiaoyi Dai; Luhua Zhang
Journal:  Antimicrob Agents Chemother       Date:  2022-05-12       Impact factor: 5.938

Review 2.  Techniques in bacterial strain typing: past, present, and future.

Authors:  Shelby R Simar; Blake M Hanson; Cesar A Arias
Journal:  Curr Opin Infect Dis       Date:  2021-08-01       Impact factor: 4.968

3.  Emergence of uncommon KL38-OCL6-ST220 carbapenem-resistant Acinetobacter pittii strain, co-producing chromosomal NDM-1 and OXA-820 carbapenemases.

Authors:  Chongmei Tian; Mengyu Xing; Liping Fu; Yaping Zhao; Xueyu Fan; Siwei Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-12       Impact factor: 6.073

4.  Description of a Rare Pyomelanin-Producing Carbapenem-Resistant Acinetobacter baumannii Strain Coharboring Chromosomal OXA-23 and NDM-1.

Authors:  Feng Zhao; Haiyang Liu; Yue Yao; Linghong Zhang; Zhihui Zhou; Sebastian Leptihn; Yunsong Yu; Xiaoting Hua; Ying Fu
Journal:  Microbiol Spectr       Date:  2022-08-10

5.  GR13-type plasmids in Acinetobacter potentiate the accumulation and horizontal transfer of diverse accessory genes.

Authors:  Robert A Moran; Haiyang Liu; Emma L Doughty; Xiaoting Hua; Elizabeth A Cummins; Tomas Liveikis; Alan McNally; Zhihui Zhou; Willem van Schaik; Yunsong Yu
Journal:  Microb Genom       Date:  2022-06

6.  Co-evolutionary adaptations of Acinetobacter baumannii and a clinical carbapenemase-encoding plasmid during carbapenem exposure.

Authors:  Linyue Zhang; Ying Fu; Linghong Zhang; Qingye Xu; Yunxing Yang; Jintao He; Sebastian Leptihn; Belinda Loh; Robert A Moran; Willem van Schaik; Mark Alexander Toleman; Qiong Chen; Lilin Liu; Yunsong Yu; Xiaoting Hua
Journal:  Evol Appl       Date:  2022-07-05       Impact factor: 4.929

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.